BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fallah A, Mohanazadeh F, Safavi M. Design, synthesis, and in vitro evaluation of novel 1,3,4-oxadiazolecarbamothioate derivatives of Rivastigmine as selective inhibitors of BuChE. Med Chem Res 2020;29:341-55. [DOI: 10.1007/s00044-019-02475-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Obaid RJ, Naeem N, Mughal EU, Al-rooqi MM, Sadiq A, Jassas RS, Moussa Z, Ahmed SA. Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase. RSC Adv 2022;12:19764-855. [DOI: 10.1039/d2ra03081k] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
2 Zhang MZ, Li WT, Li YY, Wang Q, Li C, Liu YH, Yin JX, Yang X, Huang H, Chen T. Discovery of an Oxidative System for Radical Generation from Csp3-H Bonds: A Synthesis of Functionalized Oxindoles. J Org Chem 2021;86:15544-57. [PMID: 34570502 DOI: 10.1021/acs.joc.1c02032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Krátký M, Jaklová K, Štěpánková Š, Svrčková K, Pflégr V, Vinšová J. N-[3,5-Bis(trifluoromethyl)phenyl]-5-bromo-2-hydroxybenzamide Analogues: Novel Acetyl- and Butyrylcholinesterase Inhibitors. Curr Top Med Chem 2020;20:2094-105. [PMID: 32814530 DOI: 10.2174/1568026620666200819154722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Yarmohammadi E, Beyzaei H, Aryan R, Moradi A. Ultrasound-assisted, low-solvent and acid/base-free synthesis of 5-substituted 1,3,4-oxadiazole-2-thiols as potent antimicrobial and antioxidant agents. Mol Divers 2020. [PMID: 32770458 DOI: 10.1007/s11030-020-10125-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]